Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-05-18

FDA Approved: ZYMAXID — Original Application (Allergan, Inc.)

View source ↗

Summary

FDA approved ZYMAXID (gatifloxacin) through Allergan's original NDA for the treatment of bacterial conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYMAXID (gatifloxacin)

Snippet

ORIG AP for ZYMAXID (GATIFLOXACIN)